Polymorphism of Organic Cation Transporter 2 Improves Glucose-Lowering Effect of Metformin via Influencing Its Pharmacokinetics in Chinese Type 2 Diabetic Patients

被引:0
|
作者
Wolin Hou
Dandan Zhang
Wei Lu
Taishan Zheng
Lili Wan
Qing Li
Yuqian Bao
Fang Liu
Weiping Jia
机构
[1] Shanghai Jiaotong University Affiliated Sixth People’s Hospital,Department of Endocrinology and Metabolism
[2] Shanghai Clinical Medical Center of Diabetes,Department of Pharmacy
[3] Shanghai Key Clinical Center of Metabolic Diseases,undefined
[4] Shanghai Institute for Diabetes,undefined
[5] Shanghai Key Laboratory of Diabetes,undefined
[6] Shanghai Jiaotong University Affiliated Sixth People’s Hospital,undefined
来源
关键词
Metformin; SLC22A2 Gene; Organic Cation Transporter; Glycated Albumin; Baseline HbA1c Level;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:25 / 33
页数:8
相关论文
共 50 条
  • [21] Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose-lowering therapy
    Mahdi, A.
    Kovamees, O.
    Checa, A.
    Wheelock, C. E.
    von Heijne, M.
    Alvarsson, M.
    Pernow, J.
    JOURNAL OF INTERNAL MEDICINE, 2018, 284 (04) : 388 - 398
  • [22] SGLT2 Inhibitor Ameliorates Diabetic Nephropathy Independently of Its Glucose-Lowering Effect: A Novel Mechanism for Renoprotective Effect
    Maki, Toshinobu
    Maeno, Sayaka
    Maeda, Yasutaka
    Sonoda, Noriyuki
    Wakisaka, Masanori
    Ogawa, Yoshihiro
    Inoguchi, Toyoshi
    DIABETES, 2017, 66 : A133 - A133
  • [23] Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications
    Consoli, A
    Gomis, R
    Halimi, S
    Home, P
    Mehnert, H
    Strojek, K
    Van Gaal, LF
    DIABETES & METABOLISM, 2004, 30 (06) : 509 - 516
  • [24] Tamsulosin alters the pharmacokinetics of metformin via inhibition of renal multidrug and toxin extrusion protein 1 and organic cation transporter 2 in rats
    Saad, Abdulaziz Ahmed A.
    Zhang, Fan
    Refat, Moath
    Mohammed, Eyad Abdulwhab H.
    Zhang, Mingkang
    Chen, Yuyue
    Al Hamyari, Bandar
    Alafifi, Jameel
    Wu, Xin'an
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 212
  • [25] Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study
    Simo, Rafael
    Plana-Ripoll, Oleguer
    Puente, Diana
    Morros, Rosa
    Mundet, Xavier
    Vilca, Luz M.
    Hernandez, Cristina
    Fuentes, Inmaculada
    Procupet, Adriana
    Tabernero, Josep M.
    Violan, Concepcion
    PLOS ONE, 2013, 8 (11):
  • [26] Alteration of insulin secretion and blood glucose course under glibenclamide by acarbose in type 2 diabetic patients: Additive blood glucose-lowering effect and reduced risk for hypoglycemia
    Rosak, C
    Haupt, E
    Walter, T
    Werner, J
    DIABETES, 2000, 49 : A348 - A348
  • [27] Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
    Yong, Xiaolan
    Wen, Aidong
    Liu, Xiangyang
    Liu, Haiyan
    Liu, Yan-Ping
    Li, Nan
    Hu, Tingting
    Chen, Ying
    Wang, Minquan
    Wang, Lantian
    Dai, Xiaojiao
    Huang, Juan
    Li, Jia
    Shen, Huaqiong
    CLINICAL DRUG INVESTIGATION, 2016, 36 (03) : 195 - 202
  • [28] Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
    Xiaolan Yong
    Aidong Wen
    Xiangyang Liu
    Haiyan Liu
    Yan-Ping Liu
    Nan Li
    Tingting Hu
    Ying Chen
    Minquan Wang
    Lantian Wang
    Xiaojiao Dai
    Juan Huang
    Jia Li
    Huaqiong Shen
    Clinical Drug Investigation, 2016, 36 : 195 - 202
  • [29] Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis
    Gu, Shuyan
    Hu, Xiaoqian
    Shi, Lizheng
    Zhen, Xuemei
    Sun, Xueshan
    Huang, Minzhuo
    Gu, Yuxuan
    Dong, Hengjin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [30] Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis*
    Li, Jiaxi
    Ji, Cheng
    Zhang, Wen
    Lan, Linyan
    Ge, Weihong
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (01)